These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients. van Gelder T; Smak Gregoor PJ; Weimar W Ther Drug Monit; 2000 Oct; 22(5):639. PubMed ID: 11034275 [No Abstract] [Full Text] [Related]
6. Pharmacokinetics of mycophenolate mofetil and sirolimus in children. Filler G; Bendrick-Peart J; Christians U Ther Drug Monit; 2008 Apr; 30(2):138-42. PubMed ID: 18367972 [TBL] [Abstract][Full Text] [Related]
7. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial. Hazzan M; Labalette M; Copin MC; Glowacki F; Provôt F; Pruv FR; Noël C J Am Soc Nephrol; 2005 Aug; 16(8):2509-16. PubMed ID: 15987748 [TBL] [Abstract][Full Text] [Related]
8. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus. Patel CG; Harmon M; Gohh RY; Akhlaghi F Ther Drug Monit; 2007 Feb; 29(1):87-95. PubMed ID: 17304155 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic/pharmacodynamic drug interaction between rosiglitazone and mycophenolate mofetil in kidney transplantation: a case report. Cattaneo D; Bitto A; Baldelli S; Cortinovis M; Gotti E; Perico N; Remuzzi G Transplantation; 2008 Mar; 85(6):921-2. PubMed ID: 18360279 [No Abstract] [Full Text] [Related]
10. Pharmacokinetics of oral mycophenolate mofetil in dog: bioavailability studies and the impact of antibiotic therapy. Lupu M; McCune JS; Kuhr CS; Gooley T; Storb R Biol Blood Marrow Transplant; 2006 Dec; 12(12):1352-4. PubMed ID: 17162219 [No Abstract] [Full Text] [Related]
11. Pharmacokinetics of mycophenolate mofetil in eight pediatric renal transplant patients. Aigrain EJ; Shaghaghi EK; Baudouin V; Popon M; Loirat C Transplant Proc; 2000 Mar; 32(2):388-90. PubMed ID: 10715449 [No Abstract] [Full Text] [Related]
12. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine. Lobritto SJ; Rosenthal P; Bouw R; Leung M; Snell P; Mamelok RD Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194 [TBL] [Abstract][Full Text] [Related]
13. Determination of mycophenolate area under the curve by limited sampling strategy. Yeung S; Tong KL; Tsang WK; Tang HL; Fung KS; Chan HW; Chan AY; Chan L Transplant Proc; 2001; 33(1-2):1052-3. PubMed ID: 11267186 [No Abstract] [Full Text] [Related]
14. Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience. Santos SM; Carlos CM; Cabanayan-Casasola CB; Danguilan RA Transplant Proc; 2012 Jan; 44(1):154-60. PubMed ID: 22310603 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft. Neumann I; Fuhrmann H; Kanzler M; Fang IF; Jaeger A; Graf H; Bayer P; Kovarik J Expert Opin Pharmacother; 2008 Apr; 9(6):879-86. PubMed ID: 18377332 [TBL] [Abstract][Full Text] [Related]
16. Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment. Büchler M; Lebranchu Y; Bénéton M; Le Meur Y; Heng AE; Westeel PF; le Guellec C; Libert F; Hary L; Marquet P; Paintaud G Clin Pharmacol Ther; 2005 Jul; 78(1):34-42. PubMed ID: 16003290 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporine and sirolimus interaction in a kidney transplant patient. Dabrowska-Zamojcin E; Pawlik A; Domański L; Rózański J; Droździk M Transplant Proc; 2005 Jun; 37(5):2317-9. PubMed ID: 15964407 [TBL] [Abstract][Full Text] [Related]
18. Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling. Cremers S; Schoemaker R; Scholten E; den Hartigh J; König-Quartel J; van Kan E; Paul L; de Fijter J Br J Clin Pharmacol; 2005 Sep; 60(3):249-56. PubMed ID: 16120063 [TBL] [Abstract][Full Text] [Related]
19. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus. Mardigyan V; Giannetti N; Cecere R; Besner JG; Cantarovich M J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138 [TBL] [Abstract][Full Text] [Related]